ArticleBMC pulmonary medicine2021
Endobronchial closure of the bronchopleural fistula with the ventricular septal defect occluder: a case series.
Article in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Embolization coils in treating postoperative bronchopleural fistula: a systematic review.Frontiers in medicine · 2024Pooled it
- Interventional techniques and strategies for postoperative bronchopleural fistula treatment: a narrative review.Journal of thoracic disease · 2026Review
- Thin bronchoscope-parallel, endotracheal tube-guided stent deployment for cervical tracheoesophageal fistula after anti-cancer therapy: a case report and literature review.Frontiers in medicine · 2026Article
- Management of bronchopleural fistula using Amplatzer VSD occluder device.Lung India : official organ of Indian Chest Society · 2026Article
- A pilot study of endobronchial repairment for bronchopleural fistulas.Respiratory research · 2025Article
- Article
- Case report: Endobronchial closure of postoperative bronchopleural fistula with embolization coil: a sandwich-like approach.Frontiers in medicine · 2024Article
- Bronchoscopic Closure of Bronchopleural Fistula with Occluder.Cancer management and research · 2024Review
- Bronchopleural Fistula Management With an Amplatzer Duct Occluder: A Comprehensive Case Report and Literature Review.Cureus · 2023Article
- Covered SEMS failed to cure airway fistula closed by an amplatzer device.BMC pulmonary medicine · 2023Article
- Successful surgical treatment of bronchopleural fistula caused by severe pulmonary tuberculosis: A case report and review of literature.World journal of clinical cases · 2023Article
- Progress Report on Interventional Treatment for Bronchopleural Fistula.Emergency medicine international · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
objectivesThe ventricular septal defect (VSD) occluder has been reported to be a novel method for the closure of bronchopleural fistula (BPF). Our study was to confirm the use of VSD occluder in treating BPF after pneumonectomy or lobectomy.
methodsWe performed a single-center, retrospective study of 10 consecutive patients (8 men and 2 women aged 29-70 years) with postoperative BPF receiving the VSD occluder treatment. We used the HeartR™ Membranous VSD occluder (Lifetech Scientific Co., Shenzhen, China) for the closure of BPF through flexible bronchoscopy under general anesthesia. Demographic characteristics, BPF characteristics, and clinical outcomes were collected from patients' files using the standardized data abstraction forms.
resultsThe underlying diseases were lung cancer in 6 patients, pulmonary tuberculosis in 3, and bronchiectasis in 1. Right-sided BPFs occurred in 6 patients, and left-sided BPFs occurred in 4. Five patients were underweight with a body mass index < 18.5 kg/m
conclusionsOur study demonstrated the bronchoscopic closure of BPF after lung resection using the VSD occluder is an off-label but safe and effective method. We prefer to stabilize the BPF by eradicating the underlying diseases and providing nutritional support to those receiving VSD occluder closure treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.